In a first for South Africa, Sinovac will start phase three clinical trials of a Covid-19 vaccine for children from Friday. Currently, the country has no Covid-19 vaccine approved for children. | TebogoMonama
The first Covid-19 vaccine trials in children start on Friday. 2 000 South African children will be enrolled in the phase three trials.
In a first for South Africa, Sinovac will start phase three clinical trials of a Covid-19 vaccine for children from Friday. According to Numolux, which has the approval to distribute Sinovac in South Africa, the trials will be conducted on 2 000 children aged six months to 17 years. They will be conducted at seven research sites across the country.
The trials will enrol 14 000 children from South Africa, Chile, the Philippines, Malaysia and Kenya. Sinovac currently has conditional approval from the South African Health Products Regulatory Authority . The conditions include regular safety data updates and that they only be administered to people aged 18 to 59. The vaccine is not yet distributed for adults. In a statement on Thursday, Numolux said the study would evaluate the efficacy of two doses of the vaccine against confirmed symptomatic Covid-19 cases in children and adolescents.
. If you can't find the facts you're looking for, email us at the address mentioned in the article and we will verify the information with medical professionals.In times of uncertainty you need journalism you can trust. For only, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 LIVE UPDATES | How Covid-19 language can be misunderstoodCoronavirus updates.
Read more »
Sinovac to trial Covid-19 vaccine in South African children in global studyChina's Sinovac Biotech will trial its Covid-19 vaccine in children and adolescents in South Africa as part of a global Phase III study, Sinovac and local partner Numolux Group said on Thursday.
Read more »
WATCH: Imperial grows revenue despite Covid-19 hitBusiness Day TV spoke to CEO Mohammed Akoojee for more detail
Read more »
Covid-19 travel bans need to be more pragmaticOne measure would be to allow the vaccinated more freedom to cross borders
Read more »